Clinical trial
Intranasal Oxytocin in the Treatment of Autism
NCT00490802 · Evdokia Anagnostou, Other · Completed
Key facts
| NCT number | NCT00490802 |
|---|---|
| Title | Intranasal Oxytocin in the Treatment of Autism |
| Official title | Intranasal Oxytocin in the Treatment of Autism |
| Lead sponsor | Evdokia Anagnostou, Other |
| Collaborators | Icahn School of Medicine at Mount Sinai |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Autism |
| Intervention type | Drug |
| Interventions | Oxytocin, Placebo |
| Enrollment | 19 |
| Start date | Jun 1, 2006 |
| Primary completion | Sep 1, 2011 |
| Completion | Apr 1, 2012 |
| First posted | Jun 25, 2007 |
| Last update posted | Oct 23, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: